Inr Tracking Coumadin Use With Phone App

NCT05715541 | Completed

• 1 other identifier: 20/01/2021-2021/15-01
• Study Type: interventional
• Target: 24
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to compare the INR values of the patients followed by face-to-face and telephone applications.

Conditions

Warfarin; Mobile Applications

Outcome Measures

Primary Outcomes (2)

• Comparison of the Knowledge Levels of the Groups on the Use of Coumadin

  To measure the knowledge level with "Patient Information Form" of patients using coumadin about the medication.

  It ranges from 6 months to 1 year

• Comparison of INR Control and Drug Compliance Values by Groups

  Measuring medication compliance with "The Adherence to Refills and Medications Scale" of patients using coumadin. To compare the INR values of the patients using the phone application and followed face to face.

  It ranges from 6 months to 1 year

Study Arms (1)

Comparison of INR Control and Drug Compliance Values by Groups

OTHER

Follow-up of the patients in the control group continued in the outpatient clinic. This application includes an interface where patients can enter drug treatment information such as INR values, disease diagnosis, how many times a day and how many mg they take, and a chat box section where they can communicate with their physicians, including emergencies. The doctor reviewed the patient's INR findings once they were relayed by the patient, then told them to adjust the patient's warfarin dosage and schedule the next INR check. The application sent notifications to the patients every day about when and how many mg of the drug they would take

Other: mobile applications with the name "Set My INR"

Interventions

mobile applications with the name "Set My INR" OTHER

The relevant software company assisted in developing the phone application. The language of the application created with the name "Set My INR" is Turkish. The application provided an opportunity for patients to share and communicate with their physician after having the INR value measured in a health institution near their place of residence before coming to the hospital

Comparison of INR Control and Drug Compliance Values by Groups

Eligibility Criteria

• Age: 18 Years - 90 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• at least 18 years old, using a smartphone, not having a psychiatric illness or treatment, and agreeing to participate

You may not qualify if:

• requiring medical examination, not using a smartphone, having a psychiatric illness or treatment, and not agreeing to participate

Sponsors & Collaborators

• Muhammed Onur Hanedan: lead

Study Sites (1)

Ahi Evren Göğüs Kalp ve Damar Cerrahisi Eğitim ve Araştırma Hastanesi

Trabzon, 61100, Turkey (Türkiye)

Location

Study Officials

• Muhammet Onur HANEDAN

  MD, Associate Professor1

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: MD, Associate Professor

Study Record Dates

• First Submitted: January 18, 2023
• First Posted: February 8, 2023
• Study Start: June 1, 2021
• Primary Completion: November 30, 2022
• Study Completion: November 30, 2022
• Last Updated: February 8, 2023

Record last verified: 2023-01

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)